BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32775353)

  • 1. Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma.
    Desai V; Patel K; Sheth R; Barlass U; Chan YM; Sclamberg J; Bishehsari F
    Visc Med; 2020 Jun; 36(3):220-226. PubMed ID: 32775353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients.
    Hoogenboom SA; Bolan CW; Chuprin A; Raimondo MT; van Hooft JE; Wallace MB; Raimondo M
    Pancreatology; 2021 Mar; 21(2):428-433. PubMed ID: 33485792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
    Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
    Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining age and sex-specific distribution of pancreatic whole-gland CT attenuation using artificial intelligence aided image segmentation: Associations with body composition and pancreatic cancer risk.
    Janssens LP; Weston AD; Singh D; Spears G; Harmsen WS; Takahashi N; Philbrick KA; Erickson BJ; Abu Dayyeh BK; Chari ST; Chandrasekhara V; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Majumder S
    Pancreatology; 2021 Dec; 21(8):1524-1530. PubMed ID: 34507900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty infiltration of the pancreas: a systematic concept analysis.
    Mahyoub MA; Elhoumed M; Maqul AH; Almezgagi M; Abbas M; Jiao Y; Wang J; Alnaggar M; Zhao P; He S
    Front Med (Lausanne); 2023; 10():1227188. PubMed ID: 37809324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.
    Chang ML
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma.
    Hori M; Takahashi M; Hiraoka N; Yamaji T; Mutoh M; Ishigamori R; Furuta K; Okusaka T; Shimada K; Kosuge T; Kanai Y; Nakagama H
    Clin Transl Gastroenterol; 2014 Mar; 5(3):e53. PubMed ID: 24622469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
    Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
    Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 12. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
    Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Evidence Causally Linking Pancreas Fat to Pancreatic Cancer: A Mendelian Randomization Study.
    Yamazaki H; Streicher SA; Wu L; Fukuhara S; Wagner R; Heni M; Grossman SR; Lenz HJ; Setiawan VW; Marchand LL; Huang BZ
    medRxiv; 2023 Apr; ():. PubMed ID: 37163062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images.
    Javed S; Qureshi TA; Gaddam S; Wang L; Azab L; Wachsman AM; Chen W; Asadpour V; Jeon CY; Wu B; Xie Y; Pandol SJ; Li D
    Front Oncol; 2022; 12():1007990. PubMed ID: 36439445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.
    Zaid M; Elganainy D; Dogra P; Dai A; Widmann L; Fernandes P; Wang Z; Pelaez MJ; Ramirez JR; Singhi AD; Dasyam AK; Brand RE; Park WG; Rahmanuddin S; Rosenthal MH; Wolpin BM; Khalaf N; Goel A; Von Hoff DD; Tamm EP; Maitra A; Cristini V; Koay EJ
    Front Oncol; 2020; 10():596931. PubMed ID: 33344245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
    Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
    Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
    Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Ductal Adenocarcinoma: Interface Enhancement Gradient Measured on Dual-Energy CT Images Improves Prognostic Evaluation.
    Amer AM; Li Y; Summerlin D; Burgan CM; McNamara MM; Smith AD; Morgan DE
    Radiol Imaging Cancer; 2020 Jul; 2(4):e190074. PubMed ID: 33778722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.